Evidence map›Paper›PMID 36557742›Full record

ArticleMicroorganisms2022

TLR4/CD14/MD2 Revealed as the Limited Toll-like Receptor Complex for

Romana Klasinc, Claire Battin, Wolfgang Paster, Michael Reiter, Philipp Schatzlmaier, Peter Rhein, Andreas Spittler, Peter Steinberger, Hannes Stockinger

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Seroprevalence ofLe infezioni in medicina · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Romana KlasincMedical University of Vienna, Center for Pathophysiology, Infectiology and Immunology, Institute for Hygiene and Applied Immunology, 1090 Vienna, Austria.ORCID 0000-0003-2689-5159
Claire BattinMedical University of Vienna, Center for Pathophysiology, Infectiology and Immunology, Institute of Immunology, Division of Immune Receptors and T Cell Activation, 1090 Vienna, Austria.
Wolfgang PasterMedical University of Vienna, Center for Pathophysiology, Infectiology and Immunology, Institute of Immunology, Division of Immune Receptors and T Cell Activation, 1090 Vienna, Austria.
Michael ReiterMedical University of Vienna, Center for Pathophysiology, Infectiology and Immunology, Institute for Hygiene and Applied Immunology, 1090 Vienna, Austria.ORCID 0000-0002-7435-7999
Philipp SchatzlmaierMedical University of Vienna, Center for Pathophysiology, Infectiology and Immunology, Institute for Hygiene and Applied Immunology, 1090 Vienna, Austria.
Peter RheinLuminex B.V., A DiaSorin Company, 5215 MV 's-Hertogenbosch, The Netherlands.
Andreas SpittlerMedical University of Vienna, Core Facility Flow Cytometry and Department of Surgery, Research Laboratories, 1090 Vienna, Austria.ORCID 0000-0003-2657-6836
Peter SteinbergerMedical University of Vienna, Center for Pathophysiology, Infectiology and Immunology, Institute of Immunology, Division of Immune Receptors and T Cell Activation, 1090 Vienna, Austria.ORCID 0000-0001-6848-4097
Hannes StockingerMedical University of Vienna, Center for Pathophysiology, Infectiology and Immunology, Institute for Hygiene and Applied Immunology, 1090 Vienna, Austria.ORCID 0000-0001-6404-4430
Medical University of Vienna · ATSt Anna Children's Hospital · AT

Funding

European Union's Horizon 2020 720480-ID-LYME
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chlamydia trachomatisflow cytometryimagingsignalingtoll-like receptors

Identifiers

PMID36557742
PMCPMC9783372
OpenAlexW4312195328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.